Purchase any WEBINAR and get
10% Off
CODE: SAVE10
T&C applicable, please referFAQ
Validity : 16th Oct'26 to 26th Oct'26
Pharmacovigilance in the US – Adverse Event Reporting and Drug Safety
Date & Time
Tue, December 1, 2026
10:00 AM PST
01:00 PM EST
Duration
60 Mins
Webinar ID
IQW26L1220
Level
Intermediate
Speaker
Mr.Mohammed Ilham Ahmed
- Introduction to pharmacovigilance and post-market drug safety
- Adverse event reporting and the importance of complete case information
- Safety case intake, documentation, and processing workflow
- Follow-up, duplicate detection, and data-quality considerations
- Medical terminology, coding, and clear case narratives
- Safety evaluation and escalation concepts
- Roles and responsibilities within drug-safety processes
- Quality practices in pharmacovigilance
Overview of the webinar
Pharmacovigilance plays a central role in monitoring the safety of medicines and identifying potential risks during real-world use. This webinar introduces the US pharmacovigilance landscape with a practical focus on adverse event reporting and the processes used to support drug safety. The session will explain the purpose of collecting adverse event information, the importance of timely and accurate documentation, and the overall workflow from receipt of a safety report through case processing, assessment, follow-up, and safety evaluation.
Participants will examine common data elements associated with adverse event reports and discuss challenges that can affect case quality, including incomplete information, unclear narratives, duplicate reports, inconsistent documentation, and missing follow-up details. The webinar will also address the importance of accurate medical terminology, structured documentation, data quality, and appropriate escalation of significant safety information.
The session is designed to help pharmacists, clinical research professionals, drug-safety teams, and other healthcare or life-sciences professionals understand their role in supporting reliable pharmacovigilance processes. The emphasis will be on practical awareness, quality, consistency, and patient safety rather than replacing organization-specific procedures or regulatory requirements.
Who should attend?
- Drug Safety Associate
- Pharmacovigilance Associate
- Drug Safety Pharmacist
- Clinical Research Associate
- Safety Specialist
- Medical Information Professional
- Clinical Pharmacist
- Quality Assurance Professional
Why should you attend?
Pharmacovigilance is essential to identifying, evaluating, and communicating medicine-related safety information after products enter clinical use. This webinar provides an overview of adverse event reporting and drug-safety activities within the US context, with a practical focus on the role of healthcare and life-sciences professionals. Participants will learn the purpose of adverse event reporting, the importance of complete and accurate safety information, and the major stages involved in processing and evaluating safety reports. The session will also highlight common challenges such as incomplete case information, duplicate reports, follow-up requirements, coding and documentation issues, and timely escalation of important safety information. By attending, participants will strengthen their understanding of the pharmacovigilance workflow and the importance of consistent documentation and quality practices. The webinar is intended to support professionals who contribute to drug safety, clinical research, medical information, medication safety, and related activities.
Faculty - Mr.Mohammed Ilham Ahmed
Mohammed Ilham Ahmed is a PharmD graduate and accomplished training professional with 8 years of experience spanning the Technology, Pharmacy, and Engineering sectors. He brings a rare blend of clinical pharmaceutical expertise and technical fluency, specializing in Pharmacy, the Microsoft Office Suite, and Artificial Intelligence. Known for translating complex, high-level concepts into practical, actionable learning, he empowers professionals and organizations to bridge the gap between healthcare knowledge and modern digital tools. His interdisciplinary approach and commitment to excellence make him a distinctive voice at the intersection of science, technology, and innovation.